TNFSF14 and glioblastoma: This prediction value extended to LGG patients, as LGG patients with higher LIGHT expression exhibited shorter PFS (Figure S2A, P = 0.041), while higher or lower LIGHT expression in GBM patients did not make a statistically significant difference in PFS (Figure S2A, P = 0.455).